| Dr Roland Tezeh Njei, MD | |
|
701 Superior Ave Ste J, Munster, IN 46321-4038 | |
| (219) 934-4080 | |
| (219) 934-4075 |
| Full Name | Dr Roland Tezeh Njei |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 701 Superior Ave Ste J, Munster, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235582768 | NPI | - | NPPES |
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
The Healthy Communities Research Centre at UQ Ipswich is calling for a national focus on "health literacy" following the release of findings which reveal that most Australians don't have the basic knowledge to keep themselves healthy.
An advanced study launched at Yale School of Medicine is evaluating the role of statin therapy in patients with heart failure, one of the leading causes of hospitalization in people over age 65.
Abzyme Therapeutics, a new biotechnology company dedicated to developing methods to generate human monoclonal antibodies for the treatment of disease, announced today that they have entered into an exclusive agreement with LifeSensors to license their proprietary protein expression platform, SUMOpro™. Enhanced protein expression is key to the evolution and development of antibodies and the LifeSensors
Adolescents and young adults who are heavy users of marijuana are more likely than non-users to have disrupted brain development, according to a new study.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roland Tezeh Njei, MD Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Dr Roland Tezeh Njei, MD 701 Superior Ave Ste J, Munster, IN 46321-4038 Ph: (219) 934-4080 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
The Healthy Communities Research Centre at UQ Ipswich is calling for a national focus on "health literacy" following the release of findings which reveal that most Australians don't have the basic knowledge to keep themselves healthy.
An advanced study launched at Yale School of Medicine is evaluating the role of statin therapy in patients with heart failure, one of the leading causes of hospitalization in people over age 65.
Abzyme Therapeutics, a new biotechnology company dedicated to developing methods to generate human monoclonal antibodies for the treatment of disease, announced today that they have entered into an exclusive agreement with LifeSensors to license their proprietary protein expression platform, SUMOpro™. Enhanced protein expression is key to the evolution and development of antibodies and the LifeSensors
Adolescents and young adults who are heavy users of marijuana are more likely than non-users to have disrupted brain development, according to a new study.
› Verified 8 days ago
Sahar Halabi, M.D Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 761 45th St Ste 108, Munster, IN 46321 Phone: 219-922-5416 Fax: 219-922-3745 | |
Wassim Shwaiki, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8840 Calumet Ave Ste 203, Munster, IN 46321 Phone: 219-836-7723 Fax: 219-836-7726 | |
Thottathil Viswanathan Gopan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 761 45th St Ste 110, Munster, IN 46321 Phone: 219-922-3020 Fax: 219-922-3023 | |
Dr. Kyle Kleist, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Superior Ave, Munster, IN 46321 Phone: 219-924-1300 Fax: 219-933-2288 | |
Dr. Gene Lee Chang, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9030 Columbia Ave, Munster, IN 46321 Phone: 219-836-6002 Fax: 219-836-6003 | |
Sana Shoaib Meah, D.O Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 761 45th Avenue, Suite 110, Munster, IN 46321 Phone: 219-922-3020 Fax: 219-922-3023 | |
Dr. Jay C. L.. Paik, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Macarthur Blvd, #15, Munster, IN 46321 Phone: 219-836-6411 Fax: 219-836-6415 |